Study of 6-Thioguanine in Combination With 6-Mercaptopurine During Maintenance Therapy of Childhood Lymphoma
NCT02141100
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Conditions
Non-Hodgkin Lymphoma
Interventions
DRUG:
6-thioguanine
Sponsor
Kjeld Schmiegelow
Collaborators
[object Object]
[object Object]
[object Object]